Skip to content
Trial Eligibility
Menu

SBRT Boost for Unfavorable Prostate Cancer'

NCT02016248

This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to find out whether giving a short course of focused radiation called an SBRT "boost" is a safe and effective way to treat prostate cancer. This boost delivers a high dose of radiation to the prostate in a non-invasive way, similar to what is done with high dose rate (HDR) brachytherapy but without using needles. The study looks at how well this treatment controls the cancer, what side effects it may cause, and how it affects patients' quality of life over time.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Prostate Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
Male
Healthy volunteers
Not accepted
Sponsor
MemorialCare Health System
Last updated on ClinicalTrials.gov
March 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 3

  • Orange Coast Memorial Medical Center · Fountain Valley, CA
  • Saddleback Memorial Medical Center · Laguna Hills, CA
  • Long Beach Memorial Medical Center · Long Beach, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.